Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health
Forecast
Health Resources and Services Administration plans to offer grants of up to $1.0 million to any type of organization. It expects to make about 9 awards worth $9.0 million in total. It is a forecast: the notice is expected around January 22, 2027, with applications due around March 23, 2027.
From the official notice on Grants.gov, last changed August 21, 2026. Checked October 31, 2026.
- Award ceiling$1.0 million
- Award floornot stated
- Expected awards9
- Total funding$9.0 million
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | August 21, 2026 |
|---|---|
| Expected posting | January 22, 2027 |
| Expected deadline | March 23, 2027 |
| Expected award date | August 1, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to any type of organization.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
You can apply if you are a domestic public or private, non-profit or for-profit entity. "Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. RCORP-Child and Adolescent Behavioral Health services and activities may only support HRSA-designated rural counties and rural census tracts.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The RCORP-Child and Adolescent Behavioral Health Program provides funding to rural communities to establish and expand behavioral health care services, including mental health and substance use disorder for rural children and adolescents.
How to apply
- Read the full notice and attachments on Grants.gov and the agency's announcement. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Lynlee Tanner Stapleton, ruralopioidresponse@hrsa.gov, 301-443-5764.
Questions people ask
Who can apply for Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health?
Health Resources and Services Administration accepts applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health?
Expected deadline March 23, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $1.0 million each. About $9.0 million in total across about 9 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience